1. Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice. Issue 7 (8th July 2021) Authors: Chu, Yaya; Nayyar, Gaurav; Jiang, Susiyan; Rosenblum, Jeremy M.; Soon-Shiong, Patrick; Safrit, Jeffrey T; Lee, Dean A.; Cairo, Mitchell S. Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma. Issue 2 (27th October 2020) Authors: Chu, Yaya; Nayyar, Gaurav; Kham Su, Nang; Rosenblum, Jeremy M; Soon-Shiong, Patrick; Lee, John; Safrit, Jeffrey T; Barth, Matthew; Lee, Dean; Cairo, Mitchell S Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma. Issue 2 (27th October 2020) Authors: Chu, Yaya; Nayyar, Gaurav; Kham Su, Nang; Rosenblum, Jeremy M; Soon-Shiong, Patrick; Lee, John; Safrit, Jeffrey T; Barth, Matthew; Lee, Dean; Cairo, Mitchell S Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma. Issue 2 (27th October 2020) Authors: Chu, Yaya; Nayyar, Gaurav; Kham Su, Nang; Rosenblum, Jeremy M; Soon-Shiong, Patrick; Lee, John; Safrit, Jeffrey T; Barth, Matthew; Lee, Dean; Cairo, Mitchell S Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma. Issue 2 (27th October 2020) Authors: Chu, Yaya; Nayyar, Gaurav; Kham Su, Nang; Rosenblum, Jeremy M; Soon-Shiong, Patrick; Lee, John; Safrit, Jeffrey T; Barth, Matthew; Lee, Dean; Cairo, Mitchell S Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma. Issue 2 (27th October 2020) Authors: Chu, Yaya; Nayyar, Gaurav; Kham Su, Nang; Rosenblum, Jeremy M; Soon-Shiong, Patrick; Lee, John; Safrit, Jeffrey T; Barth, Matthew; Lee, Dean; Cairo, Mitchell S Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma. Issue 2 (27th October 2020) Authors: Chu, Yaya; Nayyar, Gaurav; Kham Su, Nang; Rosenblum, Jeremy M; Soon-Shiong, Patrick; Lee, John; Safrit, Jeffrey T; Barth, Matthew; Lee, Dean; Cairo, Mitchell S Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma. Issue 2 (27th October 2020) Authors: Chu, Yaya; Nayyar, Gaurav; Kham Su, Nang; Rosenblum, Jeremy M; Soon-Shiong, Patrick; Lee, John; Safrit, Jeffrey T; Barth, Matthew; Lee, Dean; Cairo, Mitchell S Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma. Issue 2 (27th October 2020) Authors: Chu, Yaya; Nayyar, Gaurav; Kham Su, Nang; Rosenblum, Jeremy M; Soon-Shiong, Patrick; Lee, John; Safrit, Jeffrey T; Barth, Matthew; Lee, Dean; Cairo, Mitchell S Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma. Issue 2 (27th October 2020) Authors: Chu, Yaya; Nayyar, Gaurav; Kham Su, Nang; Rosenblum, Jeremy M; Soon-Shiong, Patrick; Lee, John; Safrit, Jeffrey T; Barth, Matthew; Lee, Dean; Cairo, Mitchell S Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗